Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Holley Nanhu Pharmaceutical Co., Ltd., also known as Nanhu Pharma, is a Chinese pharmaceutical company and a subsidiary of the Holley Group. Established in 1969 as the Jiaxing Nanhu Pharmaceutical Factory, the company specializes in the research, development, manufacturing, and marketing of finished pharmaceutical products. It is a major manufacturer of artemisinin-based antimalarials, including the fixed-dose combination Duo-Cotecxin (dihydroartemisinin/piperaquine phosphate). Beyond antimalarials, the company produces a range of antibiotics, including penicillins and cephalosporins, as well as gastrointestinal medications. Its manufacturing facilities in Jiaxing are GMP-certified by the NMPA and have received WHO GMP compliance for antimalarial production, supporting its role in global health initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Holley Nanhu Pharmaceutical.